The basic mitochondrial pathway of apoptosis in vertebrates (Danial and Korsmeyer, 2004) begins with the permeabilization of the mitochondrial outer membrane by proapoptotic members of the Bcl-2 family, resulting in a release of proteins from the intermembrane space into the cytosol. Among these released proteins is cytochrome c, which interacts with monomeric APAF-1 to facilitate a conformational change in the latter, leading to its oligomerization and recruitment of caspase-9 to form the apoptosome (Figure 1 ). The associated caspase-9 is thereby activated, and this in turn cleaves and activates the executioner caspases-3 and -7. These then cleave key substrates in the cell to produce the cellular and biochemical events we see as apoptosis. Other released proteins facilitate caspase activation through inactivation of endogenous inhibitors of caspases, the inhibitor of apoptosis proteins (IAPs). While activated executioner caspases clearly kill cells via apoptosis, inhibition of these proteinases only transiently protects cells; once the mitochondria permeabilize, death will proceed regardless of caspase activation, either due to other toxic mediators released from the mitochondria or eventual loss of essential mitochondrial functions (Chipuk and Green, 2005).
For more than a decade, it has been apparent that apoptosis and other forms of cell death are often controlled at one or more crucial steps involving the mitochondria. Recent findings, including an elegant investigation in a recent issue of Cell (Hao et al., 2005) , have helped to elucidate fundamental aspects of this involvement while raising puzzling new questions about mitochondrial routes to cellular demise. The emerging, if preliminary, perspective these new studies provide may represent either a refinement of our views of how cells die or, perhaps, the beginnings of what amounts to a reformulation of our ideas.
The basic mitochondrial pathway of apoptosis in vertebrates (Danial and Korsmeyer, 2004 ) begins with the permeabilization of the mitochondrial outer membrane by proapoptotic members of the Bcl-2 family, resulting in a release of proteins from the intermembrane space into the cytosol. Among these released proteins is cytochrome c, which interacts with monomeric APAF-1 to facilitate a conformational change in the latter, leading to its oligomerization and recruitment of caspase-9 to form the apoptosome (Figure 1 ). The associated caspase-9 is thereby activated, and this in turn cleaves and activates the executioner caspases-3 and -7. These then cleave key substrates in the cell to produce the cellular and biochemical events we see as apoptosis. Other released proteins facilitate caspase activation through inactivation of endogenous inhibitors of caspases, the inhibitor of apoptosis proteins (IAPs). While activated executioner caspases clearly kill cells via apoptosis, inhibition of these proteinases only transiently protects cells; once the mitochondria permeabilize, death will proceed regardless of caspase activation, either due to other toxic mediators released from the mitochondria or eventual loss of essential mitochondrial functions .
The entire process, from the initial trigger to the destruction of the cell, can take hours or even days. But the events that concern us here, beginning with the first mitochondrial changes and culminating in the activation of caspases, often take about ten minutes, and it is strongly suspected that once these events proceed to the point of executioner caspase activation without constraint, the death of the cell may be inevitable. Here, I discuss recent findings regarding these ten minutes, including caspase activation and the signals that cause mitochondrial outer membrane permeabilization (MOMP). Along the way we explore what may be simple detours from the road to ruin, or might represent important alternate routes to cellular destruction. Presently, we know of only one way in which caspase-9 can be activated, leading to apoptosis: cytochrome c induces the oligomerization of APAF-1, which recruits and dimerizes caspase-9, and this association activates the caspases. It is important to note that unlike the executioner caspases, initiator caspases such as caspase-9 cannot be activated by being cleavedactivation requires active dimerization by an adaptor molecule (Fuentes-Prior and Salvesen, 2004). Therefore, while cleavage of caspase-9 can be observed in a variety of settings, the only known adaptor/activator for caspase-9 is APAF-1 that has been triggered by cytochrome c.
By careful examination of the phenotypes and properties of mouse mutants of the three key players (cytochrome c, APAF-1, caspase-9), however, we may get glimpses of alternative routes to APAF-1 and/or caspase-9 activation. Depending on the strain background, these animals can often survive to birth and mature, albeit with growth and behavioral abnormalities that are due to developmental defects in the hypothalamus (Hao et al., 2005) ). An analysis of the response to different apoptosis inducers in cytochrome c mutant and APAF-1 null thymocytes showed intriguing differences that may suggest alternatives to the canonical pathway. While cell death in APAF-1 null thymocytes was delayed in response to multiple proapoptotic agents, the cytochrome c mutant cells died under some of these conditions (Hao et Notably, however, not all cell death in these mice proceeds normally. Another significant form of cell death, characterized as necrosis (based on morphology and lack of an effect of caspase inhibitors on the tempo and mode of death), such as that induced by high doses of hydrogen peroxide, did not proceed in these cells. Strikingly, these mice were remarkably resistant to ischemia/reperfusion injury in the heart (Baines et al., 2005;  Nakagawa et al., 2005) . The unavoidable conclusion is that cyclophilin D-dependent mPT is fundamental to a mitochondrial pathway of necrotic cell death.
The human intellect is drawn to dichotomies: the mitochondrial pathway of apoptosis involves an mPTindependent MOMP (see below), while the mitochondrial pathway of necrosis depends on and is caused by an mPT. However, things may not be so simple. The mitochondrial pathway of apoptosis is dependent on the proapoptotic Bcl-2 family proteins Bax and Bak (so called "multidomain" or BH123 proteins, see below), and the antiapoptotic Bcl-2 family members (such as Bcl-2 itself) block MOMP and this mitochondrial pathway. But Bcl-2 has also been shown to suppress cell death in the same heart ischemic/reperfusion model used in the cyclophilin D-knockout studies. Therefore modifiers of Bcl-2 function (such as the proapoptotic Bcl-2 family members) might impact on this mode of cell death. (However, ischemic injury elicits a surrounding apoptosis that might be the true target of Bcl-2 in this setting, and therefore this is by no means proof of an effect of Bcl-2 on a mitochondrial pathway of necrotic death dependent on cyclophilin D). Further, mPTinduced MOMP results in the release of cytochrome c (and all other intermembrane space proteins) and can therefore engage the mitochondrial pathway of caspase activation. That this was not observed with highdose hydrogen peroxide may be a consequence of the direct inhibitory effects of oxygen on the active site of caspases. "Grey zones" may thus exist where an mPT that is insufficient to engage necrotic death may nevertheless result in apoptosis. Future studies using these cyclophilin D-defective animals may help to define these "grey zone" deaths.
With respect to apoptosis, the process of MOMP therefore apparently depends entirely on the function of Bax and Bak to disrupt the barrier function of the outer mitochondrial membrane. Early notions that this was a function of the levels of Bax/Bak versus antiapoptotic proteins (e.g., Bcl-2, Bcl-xL, Mcl-1) envisioned a "rheostat" where death is controlled by changing the levels (and or functions) of the antiapoptotic Bcl-2 family members. Such inhibition of antiapoptotic activity is mediated by the BH3-only subfamily of the Bcl-2 proteins, which share only the third Bcl-2 homology domain with other family members. These bind to the antiapoptotic Bcl-2 proteins and neutralize their activity.
Recent studies by two groups add complexity to this simple rheostat model ( 
Cell Death and Society
There is a fundamental problem with multicellular life; selection for cell survival in proliferating cells can be antithetical to the survival of the individual. In the evolution of multicellular individuality, the selective pressures on the cell lineages had to be subsumed in the interest of organismal integrity (Buss, 1987) . This problem is solved by how our cells are "wired"; survival of a cell is dependent on the availability of factors produced by other cells, often belonging to distinct lineages. This social interaction among cells ensures that each lineage tends to be held in check, the default being death (Raff, 1992) . This idea, that death is a default (which appears to be at least superficially true at the cellular level), may not be true at the molecular level. These are emerging views of the "ten minutes" in the death of a cell that include MOMP, cytochrome c-induced activation of APAF-1, and caspase activation-ten minutes that can occur at any time following the induction of apoptosis by a stress or other death signal but that probably condemn the cell to its demise. What determines when and if a cell will face these crucial ten minutes remains murky, and we simply do not know in most cases why MOMP and its consequences occur at a particular time hours (or days) after a cell is triggered to die. As we refine our understanding of this critical event, however, we reach new levels of appreciation of the delicate balance that is cellular survival in the complex multicellular individual.
